WallStreetZenWallStreetZen

NASDAQ: DYN
Dyne Therapeutics Inc Stock Ownership - Who owns Dyne Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Dyne Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jason P. RhodesDirector2026-05-0621,926$18.18
$398.61kSell
Jason P. RhodesDirector2026-05-0617,244$18.18
$313.50kSell
Jason P. RhodesDirector2026-05-06428$18.18
$7.78kSell
Jason P. RhodesDirector2026-05-0643,621$18.18
$793.03kSell
Jason P. RhodesDirector2026-05-056,081$18.03
$109.64kSell
Jason P. RhodesDirector2026-05-053,056$18.03
$55.10kSell
Jason P. RhodesDirector2026-05-052,403$18.03
$43.33kSell
Jason P. RhodesDirector2026-05-0560$18.03
$1.08kSell
Jason P. RhodesDirector2026-05-043,136$18.00
$56.45kSell
Jason P. RhodesDirector2026-05-0461$18.00
$1.10kSell

1 of 8

DYN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when DYN insiders and whales buy or sell their stock.

DYN Shareholders

What type of owners hold Dyne Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
T Rowe Price Investment Management Inc10.63%17,540,089$308.88MInstitution
Janus Henderson Group PLC8.42%13,887,722$244.56MInstitution
Vanguard Group Inc6.80%11,215,565$197.51MInstitution
Blackrock Inc6.78%11,190,838$197.07MInstitution
Atlas Venture Life Science Advisors LLC5.53%9,130,465$160.79MInstitution
State Street Corp4.06%6,692,745$117.86MInstitution
Fmr LLC3.98%6,569,921$115.70MInstitution
Atlas Venture Fund XI LP3.98%6,562,578$115.57MInsider
Forbion Capital Fund IV Cooperatief Ua3.72%6,131,079$107.97MInsider
Fcpm III Services Bv3.31%5,462,846$96.20MInstitution

1 of 3

DYN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
DYN83.40%16.60%Net SellingNet Selling
ALMS62.16%23.09%Net Buying
GPCR31.26%10.35%Net SellingNet Selling
NKTR41.27%58.73%Net SellingNet Selling
SLNO35.50%64.50%Net SellingNet Selling
View Top Biotech Stocks

Dyne Therapeutics Stock Ownership FAQ

Who owns Dyne Therapeutics?

Dyne Therapeutics (NASDAQ: DYN) is owned by 107.82% institutional shareholders, 21.46% Dyne Therapeutics insiders, and 0.00% retail investors. Atlas Venture Fund XI LP is the largest individual Dyne Therapeutics shareholder, owning 6.56M shares representing 3.98% of the company. Atlas Venture Fund XI LP's Dyne Therapeutics shares are currently valued at $115.57M.

If you're new to stock investing, here's how to buy Dyne Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.